ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 654 filers reported holding ISHARES TR in Q4 2018. The put-call ratio across all filers is 1.94 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $242,000 | -0.4% | 2,070 | 0.0% | 0.07% | +4.6% |
| Q2 2022 | $243,000 | -15.3% | 2,070 | -5.9% | 0.06% | -3.0% |
| Q1 2022 | $287,000 | -14.6% | 2,200 | 0.0% | 0.07% | -18.3% |
| Q4 2021 | $336,000 | -5.6% | 2,200 | 0.0% | 0.08% | -17.2% |
| Q3 2021 | $356,000 | -2.5% | 2,200 | -1.3% | 0.10% | -3.9% |
| Q2 2021 | $365,000 | +14.1% | 2,230 | +4.9% | 0.10% | -2.8% |
| Q1 2021 | $320,000 | -0.6% | 2,125 | 0.0% | 0.11% | -9.4% |
| Q4 2020 | $322,000 | +11.8% | 2,125 | 0.0% | 0.12% | -5.6% |
| Q3 2020 | $288,000 | -10.3% | 2,125 | -9.4% | 0.12% | -16.2% |
| Q2 2020 | $321,000 | +26.9% | 2,345 | 0.0% | 0.15% | +5.7% |
| Q1 2020 | $253,000 | -10.6% | 2,345 | 0.0% | 0.14% | +26.1% |
| Q4 2019 | $283,000 | +21.5% | 2,345 | 0.0% | 0.11% | +11.0% |
| Q3 2019 | $233,000 | -51.3% | 2,345 | -46.5% | 0.10% | -70.0% |
| Q2 2019 | $478,000 | -4.6% | 4,385 | -2.2% | 0.33% | -8.8% |
| Q1 2019 | $501,000 | +14.6% | 4,485 | -1.0% | 0.36% | +9.0% |
| Q4 2018 | $437,000 | – | 4,530 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |